Skip to main
FBLG
FBLG logo

Fibrobiologics Inc (FBLG) Market Capitalization Overview

Market Cap: $30.95M as of Jun 13, 2025

$30.95M
Past Month-$8.09M (20.72%)
As of Jun 13, 2025, Fibrobiologics Inc (FBLG) has a market capitalization of $30.95M. Over the past 30 days, its market cap has decreased by -25.19%, while in the last 12 months, it has decreased by -55.36%.

Market capitalization represents the total value of Fibrobiologics Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Fibrobiologics Inc (FBLG) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Fibrobiologics Inc (FBLG) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Fibrobiologics Inc (FBLG) Market Cap History

DateMarket CapChange
Jun 2, 2025$29.20M-25.19%
May 1, 2025$39.03M+24.65%
Apr 1, 2025$31.32M-24.89%
Mar 3, 2025$41.69M-25.75%
Feb 3, 2025$56.15M-18.39%
Jan 2, 2025$68.80M-26.75%

Fibrobiologics Inc (FBLG) End of Year Market Cap History

DateMarket CapChange
2025$30.95M-55.36%
2024$69.32M

FAQs About Fibrobiologics Inc (FBLG) Market Cap

As of Jun 13, 2025, the market capitalization of Fibrobiologics Inc (FBLG) is $30.95M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Fibrobiologics Inc’s market capitalization has decreased by -20.72%, changing from $39.03M to $30.95M as of Jun 13, 2025.

In the last 3 months, Fibrobiologics Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Fibrobiologics Inc’s market capitalization increased from – in January to $69.32M in December, reflecting a — change.

Fibrobiologics Inc (FBLG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.